Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > Good Friday Morning ! Interesting Read !!

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron Jun 04, 2021 6:33am

158 Views

Post# 33328125

RE:Good Friday Morning ! Interesting Read !!

It's very close to being over, weeks away.

Pfizer have just completed a trial using an oral medication, that news dropped yesterday.

https://www.news-medical.net/news/20210602/HydroxychloroquineAzithromycin-therapy-at-a-higher-dose-improved-survival-by-nearly-20025-in-ventilated-COVID-patients.aspx

The trial listing is here

https://clinicaltrials.gov/ct2/show/NCT04381962?term=pfizer&cond=Covid19&draw=6&rank=45
the UCSF version (YES THAT UCSF)
https://clinicaltrials.gov/ct2/show/NCT04332107?term=pfizer&cond=Covid19&draw=7&rank=57

Pfizer also has this trial of an oral medication due to complete last month, phase 2, if updated to phase 3 may very well coe with eua.

https://clinicaltrials.gov/ct2/show/NCT04366050?term=pfizer&cond=Covid19&draw=6&rank=47
and
https://clinicaltrials.gov/ct2/show/NCT04366050?term=pfizer&cond=Covid19&draw=7&rank=51